Adial Pharmaceuticals, Inc. (ADIL)

Price & Market Data

Price: $2.05

Daily Change: -$0.25 / 12.20%

Daily Range: $2.00 - $2.34

Market Cap: $4,458,731

Daily Volume: 144,683

Performance Metrics

1 Week: 55.15%

1 Month: 27.11%

3 Months: -18.53%

6 Months: -70.90%

1 Year: -88.26%

YTD: -63.93%

About Adial Pharmaceuticals, Inc. (ADIL)

Get the latest on Adial Pharmaceuticals, Inc. (ADIL). Priced at 2.05, with a daily shift of -$0.25 / 12.20%. Market cap: 4,458,731. Crucial performance data includes YTD (-63.93%) and 1-month (27.11%) returns.

Company Details

Employees: 6

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.

Selected stocks

Prelude Therapeutics Incorporated (PRLD)

Borr Drilling Limited (BORR)

iHeartMedia, Inc. (IHRT)

Helport AI Limited (HPAI)

Galiano Gold Inc. (GAU)